PROCEPT BioRobotics (PRCT) Depreciation & Amortization (CF) (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 25.25% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $7.1 million, a 20.65% increase from a year earlier, with the FY2025 full-year figure at $6.4 million, up 22.09% from the prior year.
• Depreciation & Amortization (CF) was $2.0 million for Q2 2026 at PROCEPT BioRobotics, up from $1.7 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $2.0 million in Q2 2026 and troughed at $642000.0 in Q2 2023.
• A 5-year average of $1.2 million and a median of $1.3 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) declined 17.16% in 2022 and surged 98.79% in 2023, its largest moves.
• Over 5 years, Depreciation & Amortization (CF) stood at $663000.0 in 2022, then surged by 98.79% to $1.3 million in 2023, then rose by 10.24% to $1.5 million in 2024, then grew by 17.62% to $1.7 million in 2025, then increased by 16.38% to $2.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $2.0 million (Q2 2026), $1.7 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.